S187 inhibits uptake of gelatin by
liver cells
in vivo.
(a) Mice were injected intraperitoneally with 100 μL of Oregon
Green (OG)-tagged S187 or G187 (490 μM
polymer units in PBS). Four hours later, mice received 100 μL
of TR-gelatin solution (1.0 mg mL–1 in PBS), and
livers were collected after further 2 h. Mice treated with TR-gelatin
for 2 h were used as positive controls. Created with BioRender. (b)
Immunofluorescence analysis of liver sections: representative two-dimensional
fluorescence images obtained by confocal laser scanning with Hoechst
staining for nuclei (cyano), immunostaining for the CD206 receptor
(red), TR-gelatin (magenta), and S187 or G187 glycopolymers (green). Mice were treated with TR-gelatin only (TR-Gel)
or S187 or G187 followed by TR-gelatin (S187 + TR-gelatin or G187 + TR-gelatin, respectively)
as described in the Materials section.
Scale bars: 5 μm. Series of 0.5 and 2× magnification images
are shown in Figures S15–S17; and
(c) liver TR-gelatin uptake was quantified on liver homogenate as
relative fluorescence signal at λem = 615 nm per
mg of liver tissue homogenate. Top panel: representative emission
spectra in the 610 to 700 nm range (λex = 596 nm
for TR-gelatin quantification) from a single animal. Bottom panel,
collated data λem = 615 nm from N = 3. TR-Gel 1 and TR-Gel 2 are the positive control samples (mice
not pre-treated with glycopolymers) for S187 + TR-Gel and
G187 + TR-Gel samples, respectively. A two-tailed t-test
was performed to test significance; * P ≤
0.05.